Kubota Pharmaceutical Holdings Co., Ltd. engages in the pharmaceutical and medical device business worldwide. The company offers eyeMO, a remote retinal monitoring device for home-based and patient self-monitoring optical coherence tomography; and a NASA high-res version OCT device. It also provides Emixustat HCI compounds for Stargardt disease indications in Phase 3 clinical trials, as well as proliferative diabetic retinopathy and diabetic macular edema in Phase 2 clinical trials. The company was founded in 2002 and is headquartered in Minato, Japan.
Frequently asked questions
What sector does Kubota Pharmaceutical Holdings Co Ltd (4596) operate in?
Kubota Pharmaceutical Holdings Co Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Kubota Pharmaceutical Holdings Co Ltd (4596) current stock price?
As of the latest data, Kubota Pharmaceutical Holdings Co Ltd stock price is ¥66, with a previous close of ¥66.
What is Kubota Pharmaceutical Holdings Co Ltd (4596) current market capitalization?
Kubota Pharmaceutical Holdings Co Ltd market cap is approximately 9.26 billion.
What is Kubota Pharmaceutical Holdings Co Ltd (4596) Earnings Per Share (EPS)?
The trailing EPS is -¥11.
What is Kubota Pharmaceutical Holdings Co Ltd (4596) EBITDA?
Kubota Pharmaceutical Holdings Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -302.25 million.
Does Kubota Pharmaceutical Holdings Co Ltd (4596) pay dividends?
No. Kubota Pharmaceutical Holdings Co Ltd does not pay a dividend.
What is Kubota Pharmaceutical Holdings Co Ltd (4596) beta (volatility) score?
Kubota Pharmaceutical Holdings Co Ltd has a beta of 1.807, suggesting it is more volatile than the market.
